1. Wang, Shiyan, Zeng, Yong, Zhu, Lin, Tsao, Ming S, He, Housheng H. . The N6-methyladenosine Epitranscriptomic Landscape of Lung Adenocarcinoma. In Cancer discovery, 14, 2279-2299. doi:10.1158/2159-8290.CD-23-1212. https://pubmed.ncbi.nlm.nih.gov/38922581/
2. Thaventhiran, James E D, Lango Allen, Hana, Burren, Oliver S, Thrasher, Adrian J, Smith, Kenneth G C. 2020. Whole-genome sequencing of a sporadic primary immunodeficiency cohort. In Nature, 583, 90-95. doi:10.1038/s41586-020-2265-1. https://pubmed.ncbi.nlm.nih.gov/32499645/
3. Chen, Ye-Hui, Chen, Hang, Lin, Ting-Ting, Xue, Xue-Yi, Xu, Ning. 2023. ARPC1A correlates with poor prognosis in prostate cancer and is up-regulated by glutamine metabolism to promote tumor cell migration, invasion and cytoskeletal changes. In Cell & bioscience, 13, 38. doi:10.1186/s13578-023-00985-w. https://pubmed.ncbi.nlm.nih.gov/36814338/
4. Dai, Jingyuan, Gao, Jiahui, Dong, Hongchao. 2024. Prognostic relevance and validation of ARPC1A in the progression of low-grade glioma. In Aging, 16, 11162-11184. doi:10.18632/aging.205952. https://pubmed.ncbi.nlm.nih.gov/39012280/
5. Ji, Junpeng, Li, Huibing, Wang, Wenjun, Yuan, Bo, Shen, Tianyu. 2022. ARPC1A is regulated by STAT3 to inhibit ferroptosis and promote prostate cancer progression. In Human cell, 35, 1591-1601. doi:10.1007/s13577-022-00754-w. https://pubmed.ncbi.nlm.nih.gov/35871131/
智鼠故事 
